Skip to content

License de-identified EHR data and clinical notes for AI

Clinical notes record how clinicians reason. De-identified and linked across years, they train medical language models. Health data (patient records, medical imaging and veterinary records) stays with its owner: Rightmark describes it to buyers by counts only, the owner de-identifies it on site before any licensed delivery, and Rightmark never stores or hosts it.

Price Index, Q4 2026
AI-generated footage

De-identified EHR data and clinical notes can be licensed to medical AI and pharma teams. Specialty cohorts with years of linked labs and outcomes earn the most. Identifiers hidden in free text are the usual blocker, which is why notes usually go through Expert Determination.

Updated

Timeline
Months
de-identification and contracts come first (inferred)
You keep
Ownership
Routes: Revenue-share marketplace (non-exclusive revenue share); Direct license to a medical AI developer (non-exclusive).

Why AI buyers want it

Language models for medicine need real clinical writing: symptoms, differentials, plans and follow-ups. Pharma needs longitudinal patient journeys as evidence for drug development.

Think of it this way

A patient record is a long case study written by many authors. De-identified, it teaches without telling anyone the patient story.

What sets the price

  • Longitudinal depth: years of history per patient.
  • Specialty cohorts and rare conditions.
  • Linked labs, medications, imaging and outcomes.
  • Free-text notes, not only structured codes.

No buyer publishes per-patient prices. The estimate on this page is our range for what a revenue share could total for a health system with linked, multi-year records under Expert Determination.

What blocks a deal, and the fix

Identifiers hidden in free text
Clinical de-identification tuned for notes, then verified by a qualified expert under Expert Determination.
Consent language and institutional review
We work within your governance and IRB processes, and nothing is scoped before they sign off.
Patients in the UK or EU
GDPR special-category rules apply; access often runs through approved research routes or anonymization that meets the GDPR standard.

What owners overlook

  • Linking tokens let buyers join your records with claims or labs without identities.
  • Free-text notes are often worth more than the structured codes beside them, because language models learn from the writing.
  • Europe is opening regulated secondary access to health data for approved developers, which may erode exclusivity premiums there over time.

Market evidence

How a deal works

  1. Appraise

    Answer a few questions about your records. See what affects the price and whether an indicative range is available. No files, no access.

    About a minute

  2. Verify title

    We confirm you control the data, read your vendor and data-use contracts, and plan de-identification to the HIPAA standard before anything leaves your systems.

    Before any offer

  3. Route

    We match the data to the license routes that fit it and show you the terms of each before you decide. Nothing is offered without your approval.
  4. Sign and get paid

    You approve the agreement and its scope before anything moves. We never hold your passwords. Transfers use scoped, revocable connections your admins approve, or exports.

    Allow months: de-identification and contracts come first

Questions

Do patients need to consent?

Under HIPAA, properly de-identified data does not require patient authorization. Some institutions and states add their own rules, so we check them with you before any record is scoped.

Source: HHS, (opens in a new tab)

What is a linking token?

A one-way code that lets the same person's records be joined across datasets without revealing who they are.

How is EHR data priced?

Usually as a revenue share; no buyer publishes per-patient prices. Specialty cohorts with long histories and linked labs, medications, imaging or outcomes command the highest value. For 50,000 patients at $1.72 to $17 per patient, our estimate is $86,000 to $860,000 at Low confidence, not an offer.

Safe Harbor or Expert Determination for clinical notes?

Expert Determination usually suits notes and longitudinal records: a qualified expert certifies a very small re-identification risk and real dates can stay, which buyers value. Safe Harbor removes a fixed list of identifiers, including every date element except the year.

Source: HHS, (opens in a new tab)

Can UK or EU patient records be licensed?

Only within GDPR special-category rules, which usually means approved research routes or anonymization that meets the GDPR standard. We check this before any UK or EU data is scoped.

Sources: Official Journal of the European Union, (opens in a new tab); Official Journal of the European Union, (opens in a new tab)

Do you need access to our EHR?

No. We never hold your passwords. Transfers use scoped, revocable connections your admins approve, or exports. You approve the agreement and its scope before any record moves, and you warrant that your agreements and consents allow the license.

Get an indicative range for your Clinical notes and EHR data.

About a minute to appraise. No files, no access.

Find out what your data could be worth.

Start with an indicative appraisal. No files or system access needed.

Appraise your data

What brings you to Rightmark?